SECOND SIGHT MEDICAL PRODUCTS, INC. (NASDAQ:EYES) Files An 8-K Other Events

SECOND SIGHT MEDICAL PRODUCTS, INC. (NASDAQ:EYES) Files An 8-K Other Events

SECOND SIGHT MEDICAL PRODUCTS, INC. (NASDAQ:EYES) Files An 8-K Other EventsItem 7.01 Other Events On April 11, 2019, Second Sight Medical Products, Inc. (the “Company”) issued a press release announcing that Dr. Jessy D. Dorn, Ph.D., Sr. Director of Scientific Research, will present an update on the Early Feasibility Study of the Orion® Visual Cortical […]

The post SECOND SIGHT MEDICAL PRODUCTS, INC. (NASDAQ:EYES) Files An 8-K Other Events appeared first on Market Exclusive.

ATYR PHARMA, INC. (NASDAQ:LIFE) Files An 8-K Entry into a Material Definitive Agreement

ATYR PHARMA, INC. (NASDAQ:LIFE) Files An 8-K Entry into a Material Definitive Agreement

ATYR PHARMA, INC. (NASDAQ:LIFE) Files An 8-K Entry into a Material Definitive AgreementItem 8.01 Entry into a Material Definitive Agreement. On April 10, 2019, aTyr Pharma, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with an institutional investor, The Federated Kaufmann Small Cap Fund, and with Paul Schimmel, Ph.D., a director […]

The post ATYR PHARMA, INC. (NASDAQ:LIFE) Files An 8-K Entry into a Material Definitive Agreement appeared first on Market Exclusive.

INNOVUS PHARMACEUTICALS, INC. (OTCMKTS:INNV) Files An 8-K Regulation FD Disclosure

INNOVUS PHARMACEUTICALS, INC. (OTCMKTS:INNV) Files An 8-K Regulation FD Disclosure

INNOVUS PHARMACEUTICALS, INC. (OTCMKTS:INNV) Files An 8-K Regulation FD DisclosureItem 7.01 –Regulation FD Disclosure: Corporate Presentation On April 11, 2019, the Company provided an update to its corporate presentation. The presentation will be available on the Company’s website atwww.innovuspharma.comand filed herewith as Exhibit 99.1. The information set forth in this Item 7.01, including Exhibit 99.1, […]

The post INNOVUS PHARMACEUTICALS, INC. (OTCMKTS:INNV) Files An 8-K Regulation FD Disclosure appeared first on Market Exclusive.

Rite Aid Corporation (NYSE:RAD) Files An 8-K Results of Operations and Financial Condition

Rite Aid Corporation (NYSE:RAD) Files An 8-K Results of Operations and Financial Condition

Rite Aid Corporation (NYSE:RAD) Files An 8-K Results of Operations and Financial ConditionItem 2.02. Results of Operations and Financial Condition. On April11, 2019, Rite Aid Corporation (the “Company”) reported its financial position and results of operations as of and for the thirteen and fifty-two week fiscal year ended March2, 2019. The press release includes the […]

The post Rite Aid Corporation (NYSE:RAD) Files An 8-K Results of Operations and Financial Condition appeared first on Market Exclusive.

Monaker Group, Inc. (OTCMKTS:MKGI) Files An 8-K Entry into a Material Definitive Agreement

Monaker Group, Inc. (OTCMKTS:MKGI) Files An 8-K Entry into a Material Definitive Agreement

Monaker Group, Inc. (OTCMKTS:MKGI) Files An 8-K Entry into a Material Definitive AgreementItem 1.01 Entry into a Material Definitive Agreement. On April 10, 2019 and effective on February 8, 2019, Monaker Group, Inc. (the “Company”, “we” and “us”), entered into an Inducement Agreement with Verus International, Inc., formerly Realbiz Media Group, Inc. (“Verus” and the […]

The post Monaker Group, Inc. (OTCMKTS:MKGI) Files An 8-K Entry into a Material Definitive Agreement appeared first on Market Exclusive.

INNOVUS PHARMACEUTICALS, INC. (OTCMKTS:INNV) Files An 8-K Regulation FD Disclosure

INNOVUS PHARMACEUTICALS, INC. (OTCMKTS:INNV) Files An 8-K Regulation FD Disclosure

INNOVUS PHARMACEUTICALS, INC. (OTCMKTS:INNV) Files An 8-K Regulation FD DisclosureItem 7.01 –Regulation FD Disclosure: Corporate Presentation On April 11, 2019, the Company provided an update to its corporate presentation. The presentation will be available on the Company’s website atwww.innovuspharma.comand filed herewith as Exhibit 99.1. The information set forth in this Item 7.01, including Exhibit 99.1, […]

The post INNOVUS PHARMACEUTICALS, INC. (OTCMKTS:INNV) Files An 8-K Regulation FD Disclosure appeared first on Market Exclusive.

Rite Aid Corporation (NYSE:RAD) Files An 8-K Results of Operations and Financial Condition

Rite Aid Corporation (NYSE:RAD) Files An 8-K Results of Operations and Financial Condition

Rite Aid Corporation (NYSE:RAD) Files An 8-K Results of Operations and Financial ConditionItem 2.02. Results of Operations and Financial Condition. On April11, 2019, Rite Aid Corporation (the “Company”) reported its financial position and results of operations as of and for the thirteen and fifty-two week fiscal year ended March2, 2019. The press release includes the […]

The post Rite Aid Corporation (NYSE:RAD) Files An 8-K Results of Operations and Financial Condition appeared first on Market Exclusive.